alexa Multiple Sclerosis Impact Factor|omicsgroup|Journal Of Multiple Sclerosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Multiple Sclerosis Impact Factor

Multiple sclerosis is an inflammatory autoimmune-mediated disease of the Central Nervous System (CNS). Different treatment protocols, based on neurotropic viral infections and/or immunization with CNS proteins, have been implemented. Although there are encouraging outcomes, cure is still far from reach. While MS is considered to be a disease of the colder climate, primarily affecting North America and Europe, recent evidence suggests that this disease is prevalent in areas like Japan, China and the Middle East (unpublished observation), countries traditionally considered low-incidence regions. MS is now probably affecting over 2.5 million people worldwide. The disease starts at a young age of 20-40 and accompanies the patient throughout the life, resulting in a damaging socio-economic impact. Thus even more than other human diseases, MS research needs to develop effective and specific therapies. Multiple Sclerosis: Animal Models and Treatment Options Mokhtarian F. As this is one of the most prominent disease to be addressed, we believe that active research and research publications has to be made in this area of research. This was the aim behind the establishment of a journal individually focussing on this area of research. Since we are in the initial stage of journal development, journal improvement, quality maintenance and relevant research focus are the major focus areas of the journal.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top